Variant

Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting

Retrieved on: 
Tuesday, March 5, 2024

SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Researchers from Invitae (OTC: NVTA), a leading medical genetics company, are showcasing their work next week at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting in Toronto, Canada from March 12-16. The meeting's clinical agenda will include presentations on both research and clinical topics that promote the science and practice of clinical genetics and genomics.

Key Points: 
  • SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Researchers from Invitae (OTC: NVTA), a leading medical genetics company, are showcasing their work next week at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting in Toronto, Canada from March 12-16.
  • The meeting's clinical agenda will include presentations on both research and clinical topics that promote the science and practice of clinical genetics and genomics.
  • "The ACMG Annual Clinical Genetics Meeting is an incredible opportunity for our researchers and collaborators to highlight ongoing scientific advancements to support genetics-informed patient care," said W. Michael Korn, M.D., chief medical officer at Invitae.
  • Invitae plans to present posters (P164 and P073) about Lynch syndrome and VUS in mismatch repair (MMR) genes and multiplex assays of variant effects (MAVEs).

Variant Investments Names Kristi Combs Chief Operating Officer, Expands Teams Amid Growth of Interval Fund Strategies

Retrieved on: 
Thursday, November 9, 2023

PORTLAND, Ore., Nov. 9, 2023 /PRNewswire/ -- Variant Investments, LLC (Variant), an employee-controlled alternative credit and interval fund specialist, today announced the appointment of industry veteran Kristi Combs as chief operating officer, a new position.

Key Points: 
  • PORTLAND, Ore., Nov. 9, 2023 /PRNewswire/ -- Variant Investments, LLC (Variant), an employee-controlled alternative credit and interval fund specialist, today announced the appointment of industry veteran Kristi Combs as chief operating officer, a new position.
  • Variant also hired four more new employees in October across the firm's investment, operations and investor relations teams.
  • In addition to Combs, the following employees joined Variant in October:
    "We're pleased to attract these five talented professionals to our growing investment boutique," Elsasser said.
  • The Variant Alternative Income Fund (NICHX), with nearly $3 billion in assets, was introduced as an interval fund on Oct. 1, 2018.

Invitae to Present Data at The American Clinical Genetics Meeting 2023 That Supports Removing Barriers to Genetic Testing

Retrieved on: 
Wednesday, March 15, 2023

SAN FRANCISCO, March 15, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced seven studies, including one oral presentation and six posters, to be presented at the 2023 American Clinical Genetics Meeting held in Salt Lake City from March 14-18, 2023. The research reinforces the importance of universal genetic testing for patients with cancer, with much of the data highlighting the need for increased representation in clinical genetic testing data across racial, ethnic and ancestry groups that have long been underrepresented in genetic studies and databases. Such inclusion can uncover unique insights and expand the clinical validity of genetic testing to more populations, helping inform health journeys and potentially improving health outcomes. Invitae will also be highlighting powerful innovative technological advances that include multiplex assays of variant effects, machine learning and big data approaches to address current challenges in variant classification and promote reduction of variants of uncertain clinical significance (VUS).

Key Points: 
  • The research reinforces the importance of universal genetic testing for patients with cancer, with much of the data highlighting the need for increased representation in clinical genetic testing data across racial, ethnic and ancestry groups that have long been underrepresented in genetic studies and databases.
  • Such inclusion can uncover unique insights and expand the clinical validity of genetic testing to more populations, helping inform health journeys and potentially improving health outcomes.
  • Several studies being presented at ACMG will highlight evidence around the benefits of genetic testing insights to advance testing as a standard of care for all patients.
  • Oral presentation: Titled: Real world impact of germline genetic testing on clinical decision making for prostate cancer patients.

Interval Fund Manager Variant Investments Adds Kudu Investment Management as Strategic Capital Partner

Retrieved on: 
Thursday, January 19, 2023

NEW YORK and PORTLAND, Ore., Jan. 19, 2023 /PRNewswire/ -- Variant Investments, LLC (Variant), an SEC-registered alternative credit specialist and interval fund manager, and Kudu Investment Management, LLC (Kudu), a provider of permanent capital solutions to independent asset and wealth managers worldwide, today announced that Kudu has made a minority investment in Variant.

Key Points: 
  • NEW YORK and PORTLAND, Ore., Jan. 19, 2023 /PRNewswire/ -- Variant Investments, LLC (Variant), an SEC-registered alternative credit specialist and interval fund manager, and Kudu Investment Management, LLC (Kudu), a provider of permanent capital solutions to independent asset and wealth managers worldwide, today announced that Kudu has made a minority investment in Variant.
  • Portland, Ore.-based Variant remains employee-controlled and is led by Bob Elsasser, Curt Fintel, and J.B. Hayes, co-founders and principals.
  • Variant manages more than $2.3 billion, largely for registered investment advisor (RIA) clients.
  • "In Kudu, we have a partner with a keen understanding of founder-led firms that provide investors with differentiated strategies," Hayes said.

Anonos’ Webinar Series for International Data Privacy Professionals Confirms Pressing Industry Challenges and Growing Interest in Statutory Pseudonymization

Retrieved on: 
Tuesday, November 29, 2022

Anonos , global data privacy and security innovator, recently sponsored three webinars with the International Association of Privacy Professionals (IAPP).

Key Points: 
  • Anonos , global data privacy and security innovator, recently sponsored three webinars with the International Association of Privacy Professionals (IAPP).
  • Technical measures can protect against CLOUD Act requests and help reconcile Schrems II issues with EU data subject data.
  • Anonos is hosting a new webinar, The Business Benefits of Data Privacy & Security, about how the data-driven enterprise can increase data utility across the seven most critical use cases.
  • Anonos is a global innovator in data privacy and security, providing the only software platform that protects data in use with total accuracy.

Anonos Acquires Award-Winning Synthetic Data Company Statice

Retrieved on: 
Wednesday, November 2, 2022

Anonos , provider of the only technology that protects data in use with 100% accuracy, today announced the acquisition of Berlin-based Statice GmbH , a synthetic data software provider.

Key Points: 
  • Anonos , provider of the only technology that protects data in use with 100% accuracy, today announced the acquisition of Berlin-based Statice GmbH , a synthetic data software provider.
  • The Statice synthetic data technology will be integrated with the Anonos Data Embassy platform and available later this quarter.
  • Data Embassy delinks data from both direct and indirect identifiers to obscure identity while enabling organizations to use more of their data for lawful analytics, artificial intelligence, machine learning, data sharing and data transfer.
  • Thanks to the privacy guarantees of the Statice data anonymization software, companies generate privacy-preserving synthetic data compliant for any type of data integration, processing and dissemination.

U.S. Xpress Announces Realignment Plan

Retrieved on: 
Wednesday, September 7, 2022

U.S. Xpress Enterprises, Inc. (NYSE: USX) today announced a realignment plan focused on improving operating profitability and cash flow as well as reducing balance sheet leverage.

Key Points: 
  • U.S. Xpress Enterprises, Inc. (NYSE: USX) today announced a realignment plan focused on improving operating profitability and cash flow as well as reducing balance sheet leverage.
  • Mr. Fuller noted, Our goal is to make the realignment as seamless as possible for our customers and professional drivers.
  • As part of the realignment plan, the Company has identified significant personnel efficiencies as a result of eliminating organizational overlaps and duplicative functions.
  • The conference call can be accessed live by dialing 1-877-423-9813 or, for international callers, 1-201-689-8573 and asking to be joined to the US Xpress Realignment Plan conference call.

OUTCOME GROUP ANNOUNCES COMMITMENT FROM VARIANT IMPACT FUND TO DRIVE PORTFOLIO EXPANSION

Retrieved on: 
Thursday, August 25, 2022

NEW YORK, Aug. 25, 2022 /PRNewswire/ -- Outcome Group Inc (Outcome), an outcome-based education financing company, today announced it has secured a new debt facility from Variant Investments, LLC (Variant) and its Variant Impact Fund (IMPCX) which will allow Outcome to accelerate the growth of its education lending programs.

Key Points: 
  • NEW YORK, Aug. 25, 2022 /PRNewswire/ -- Outcome Group Inc (Outcome), an outcome-based education financing company, today announced it has secured a new debt facility from Variant Investments, LLC (Variant) and its Variant Impact Fund (IMPCX) which will allow Outcome to accelerate the growth of its education lending programs.
  • The Variant Impact Fund takes that a step further, providing investors with a diversified portfolio of unconventional cash-flowing assets that are aligned with the United Nations Sustainable Development Goals.
  • The Variant Impact Fund (the "Fund") offers investors efficient access to a diversified portfolio of unconventional income-generating assets aligned with the United Nations Sustainable Development Goals ("UN SDGs").
  • To learn more about Outcome Group, please visit www.outcomegroup.org
    To learn more about Variant Investments, LLC, please visit www.variantinvestments.com
    An investment in the Variant Impact Fund is speculative, involves substantial risks.

Brand Institute President of Nonproprietary Naming Division Advises Clients on Guidance Set Forth by INN Regarding COVID-19 Variant Vaccines

Retrieved on: 
Wednesday, August 3, 2022

"Vaccine variants have minimal changes in their structure compared to the structure of an existing INN.

Key Points: 
  • "Vaccine variants have minimal changes in their structure compared to the structure of an existing INN.
  • The name for the variant is linked to the original INN by a random two- or three-letter prefix.
  • Ms. Fuerst has spent her career in nonproprietary naming, first as United States Adopted Name (USAN) Secretariat and afterward opening the Nonproprietary Naming Division within Brand Institute's Drug Safety Institute.
  • Drug Safety Institute (DSI) is a wholly owned subsidiary of Brand Institute that provides Brand Institute's healthcare clients with industry-leading guidance pertaining to drug name safety, packaging, and labeling.

Variant Adds 5 to Investment Team amid AUM Growth and Impact Fund Launch

Retrieved on: 
Thursday, June 16, 2022

The additions will support the continued growth of the flagship fund, the Variant Alternative Income Fund (NICHX), as well as the recently launched Variant Impact Fund (IMPCX).

Key Points: 
  • The additions will support the continued growth of the flagship fund, the Variant Alternative Income Fund (NICHX), as well as the recently launched Variant Impact Fund (IMPCX).
  • Variant is also announcing the addition of two new Associates to the investments team, building out the next generation of investment professionals.
  • Variant Investments, LLC is a Signatory of PRI | Principles for Responsible Investment and a member of the Global Impact Investing Network.
  • The Variant Alternative Income Fund and Variant Impact Fund are continuously-offered, non-diversified, registered closed-end fund with limited liquidity.